Skip to main content
. 2019 Apr 29;19:136. doi: 10.1186/s12887-019-1508-5

Table 2.

Difference between acute anti-seizure medication in the group treated with valproic acid and the group treated with levetiracetam matched by gender and main convulsion type variables

Valproic acid Levetiracetam
N n % N n % p-value
Etiology 17 17
 Ischemic infarction 3 17.65 7 41.18
 HIE 2 2 11.76 0 0.00
 HIE 3 0 0.00 1 5.88
 Intracranial hemorrhage 4 23.53 2 11.76
 Intracranial infection 3 17.65 0 0.00
 Cerebral malformation 0 0.00 1 5.88
 Metabolic disorder 1 5.88 0 0.00
 Inborn error of metabolism 0 0.00 1 5.88
 Benign epileptic syndromes 3 17.65 3 17.65
 Severe epileptic syndromes 1 5.88 1 5.88
 Unknown 0 0.00 1 5.88
Number of emergency drugs 17 16 0.012
 0 1 5.88 1 6.25
 1 1 5.88 8 50.00
 2 7 41.18 6 37.50
 3 8 47.06 1 6.25
First-line emergency drug 17 16 0.097
 0 1 5.88 1 6.25
 diazepam 9 52.94 3 18.75
 phenobarbital 5 29.41 12 75.00
 phenytoin 1 5.88
 clonazepam 1 5.88
Second-line emergency drug 15 7 0.700
 diazepam 1 6.67
 phenobarbital 9 60.00 3 42.86
 phenytoin 4 26.67 3 42.86
 clonazepam 1 6.67 1 14.29
Third-line emergency drug 8 1 0.708
 phenytoin 7 87.50 1 100.00
 clonazepam 1 12,50

HIE hypoxic-ischemic encephalopathy